Home / About Sudair / Strategic Partnerships
Sudair Pharma collaborates with leading global pharmaceutical companies, academic institutions, and strategic partners to strengthen pharmaceutical manufacturing, support technology transfer, and advance pharmaceutical localization in Saudi Arabia.
At Sudair Pharma, partnerships are at the core of our growth strategy. By combining international expertise with local manufacturing excellence, we create sustainable healthcare solutions that support pharmaceutical localization, technology transfer, and scientific innovation.
Our collaborations enable us to deliver advanced therapies, strengthen national healthcare capabilities, and contribute to Saudi Vision 2030.

At Sudair Pharma, partnerships are at the core of our growth strategy. By combining international expertise with local manufacturing excellence, we create sustainable healthcare solutions that support pharmaceutical localization, technology transfer, and scientific innovation.
Our collaborations enable us to deliver advanced therapies, strengthen national healthcare capabilities, and contribute to Saudi Vision 2030.

Sudair Pharma collaborates with internationally recognized pharmaceutical companies to strengthen manufacturing capabilities, support technology transfer, and accelerate pharmaceutical localization through long-term strategic partnerships.
Sudair Pharma collaborates with internationally recognized pharmaceutical companies to strengthen manufacturing capabilities, support technology transfer, and accelerate pharmaceutical localization through long-term strategic partnerships.
Digital Transformation Partnership supporting digital innovation and modern manufacturing technologies.
Healthcare Collaboration strengthening pharmaceutical supply chains and supporting national healthcare initiatives.
Strengthening relationships with government entities, healthcare organizations, and global pharmaceutical companies while showcasing Sudair Pharma’s manufacturing capabilities.
Uzbekistan Delegation exploring opportunities in pharmaceutical localization, manufacturing expansion, and international investment.